Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study
INTRODUCTION: Cerebral palsy is the most common cause of physical disability in children. Spasticity is a disabling clinical symptom that is prevalent among patients suffering from cerebral palsy. The treatment of spasticity with botulinum toxin type A (BTX-A) is a well-established option in the int...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2010-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000600009 |